Standout Papers

The revised JBI critical appraisal tool for the assessment of risk of bias for randomized c... 2022 2026 2023 2024385
  1. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials (2023)
    Timothy Hugh Barker, Jennifer Stone et al. JBI Evidence Synthesis
  2. Revising the JBI quantitative critical appraisal tools to improve their applicability: an overview of methods and the development process (2022)
    Timothy Hugh Barker, Jennifer Stone et al. JBI Evidence Synthesis
  3. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies (2024)
    Timothy Hugh Barker, Nahal Habibi et al. JBI Evidence Synthesis

Immediate Impact

62 standout
Sub-graph 1 of 21

Citing Papers

Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment
2025 Standout
2 intermediate papers

Works of Jennifer Stone being referenced

Was there really any evidence that rosiglitazone increased the risk of myocardial infarction or death from cardiovascular causes?
2014
Comorbidities, Exposure to Medications, and the Risk of Community-Acquired Clostridium difficile Infection: A Systematic Review and Meta-analysis
2014

Author Peers

Author Last Decade Papers Cites
Jennifer Stone 104 85 168 191 190 46 1.3k
Chenglin Ye 158 126 319 142 138 29 1.3k
Jean‐Baptist du Prel 99 92 251 111 236 38 1.4k
Jennifer Pillay 70 48 315 301 228 45 1.5k
Amy Salter 44 167 184 209 213 47 1.5k
Linlu Ma 39 45 116 170 154 25 1.4k
Candice Estellat 157 138 131 309 392 53 1.5k
Deborah H. Charbonneau 82 94 329 211 193 39 1.7k
Stephanie Chang 201 213 316 213 216 47 1.7k
Eugene Waclawski 36 92 253 143 135 23 1.3k
Greta Castellini 118 94 94 234 173 87 1.4k

All Works

Loading papers...

Rankless by CCL
2026